Willamette Angel Conference
222 First Ave West, Albany, Oregon, 97321, United States
Overview
The Willamette Angels Conference is an exciting component of the South Willamette’s startup ecosystem. Founded in 2009, the Willamette Angels Conference (WAC) is an investment conference, connecting early stage and seed startups with angel and venture investors. It was founded in 2012 and headquartered in Eugene, Oregon.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Association
- Financial Services
Investment portfolio
- DesignMedix
Participated · Equity · Jul 2014
DesignMedix is a Portland, Oregon-based biotech developing drugs to overcome drug resistance, with an initial focus on oral malaria treatments. Founded in 2008 and led by Dr. Sandra Shotwell (president and COO), the company is building a pipeline that also targets new anti-bacterial drugs. It holds exclusive rights to four issued patents related to malaria drug candidates. DesignMedix plans to use recent financing to advance preclinical development across its pipeline. The company recently closed a $1.5M second round of angel funding and was awarded a $3M grant from the National Institutes of Health to support preclinical development of its malaria drug. Its lab and office are housed in the PSU Business Accelerator.
Team
No current team members are available.